Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
Molecular Cancer Therapeutics
|
May 5, 2017
Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors
Julie L Wilsbacher, Min Cheng, Dong Cheng, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 15, 2017
SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT)
Michael L Curtin, H Robin Heyman, Richard F Clark, et al.
Journal of Environmental Quality
|
April 4, 2022
P-FLUX: A phosphorus budget dataset spanning diverse agricultural production systems in the United States and Canada
M R Williams, P Welikhe, J Bos, et al.
ACS Medicinal Chemistry Letters
|
October 15, 2014
Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity
Zhi-Fu Tao, Lisa Hasvold, Le Wang, et al.
Nature Medicine
|
January 8, 2013
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J Souers, Joel D Leverson, Erwin R Boghaert, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
Molecular Cancer Therapeutics
|
May 5, 2017
Discovery and Characterization of Novel Nonsubstrate and Substrate NAMPT Inhibitors
Julie L Wilsbacher, Min Cheng, Dong Cheng, et al.
Bioorganic & Medicinal Chemistry Letters
|
June 15, 2017
SAR and characterization of non-substrate isoindoline urea inhibitors of nicotinamide phosphoribosyltransferase (NAMPT)
Michael L Curtin, H Robin Heyman, Richard F Clark, et al.
Journal of Environmental Quality
|
April 4, 2022
P-FLUX: A phosphorus budget dataset spanning diverse agricultural production systems in the United States and Canada
M R Williams, P Welikhe, J Bos, et al.
ACS Medicinal Chemistry Letters
|
October 15, 2014
Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity
Zhi-Fu Tao, Lisa Hasvold, Le Wang, et al.
Nature Medicine
|
January 8, 2013
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J Souers, Joel D Leverson, Erwin R Boghaert, et al.
Page
of 4